Neurofibromatosis-1 is a common autosomal-dominant genetic disorder associated with numerous physical anomalies and an increased incidence of attention-deficit hyperactivity disorder (ADHD). Studies of children with idiopathic ADHD have suggested a link between corpus callosum size and symptom severity. This study examines the contribution of corpus callosum morphology to symptoms of ADHD in children with neurofibromatosis. Eighteen control subjects and 36 children with neurofibromatosis underwent magnetic resonance imaging of the brain. Twelve subjects with neurofibromatosis had evidence of ADHD and 24 did not. Subjects with neurofibromatosis had significantly larger total corpus callosum area and significantly larger regional measurements in three of seven areas. However, there were no differences between the neurofibromatosis alone and neurofibromatosis plus ADHD groups. Increased severity of attention problems was associated with smaller total callosal areas. These results suggest that some features of ADHD in children with neurofibromatosis could be linked to quantifiable differences in brain morphology, but the nature of the genetic mutation in neurofibromatosis suggests that neurochemical effects also could be important. (J Child Neurol 2000;15:90-96).
Get full access to this article
View all access options for this article.
References
1.
National Institutes of Health Consensus Development Conference: Neurofibromatosis: Conference statement Arch Neurol 1988;45:575-578.
2.
Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl JMed1981;305:1617-1627.
3.
Hofman KJ, Harris EL, Bryan N., Denckla M.: Neurofibromatosis type 1: The cognitive phenotype. J Pediatr1994;124:S1-S8.
4.
North K., Joy P., Yuille D., et al: Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol1995;37:427-436.
5.
Denckla MB, Hofman K., Mazzocco Mmm, et al: Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet1996;67:98-102.
6.
North KN, Riccardi V., Samango-Sprouse C., et al: Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 Cognitive Disorders Task Force. Neurology1997;48:1121-1127.
7.
Eliason MJ: Neurofibromatosis: Implications for learning and behavior. J Dev Behav Pediatr1986;7:175-179.
8.
Riccardi VM: The multiple forms of neurofibromatosis. Pediatr Rev1982;3:293-298.
9.
Moore BD, Slopis JM, Schomer MD, et al: Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology1996;46:1660-1668.
Yamanouchi H., Kato T., Matsuda H., et al: MRI in neurofibromatosis type 1: Using fluid attenuated inversion recovery pulse sequences. Pediatr Neurol1995;12:286-290.
12.
Duffner P., Cohen M., Seidel G., Shucard D.: The significance of MRI abnormalities in children with neurofibromatosis . Neurology1989;39:373-378.
13.
Listernick R. , Charrow J., Greenwald MJ, Easterly NB: Optic gliomas in children with neurofibromatosis type 1. J Pediatr1988;114:788-792.
14.
DiMario FJ, Ramsby G.: Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol1998;55:500-505.
15.
Sherman JL: Imaging, in Mulvihill JJ (moderator): Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis): An update. Ann Intern Med1990;113:39-52.
16.
Moore BD 3rd , Ater JL, Needle MN, et al: Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol1994;9:368-377.
17.
North K., Joy P., Yuille D., et al: Learning difficulties in neurofibromatosis type 1: The significance of MRI abnormalities. Neurology1994;44:878-883.
18.
Lou HC, Henriksen L., Bruhn P., et al: Striatal dysfunction in attention deficit and hyperkinetic disorder . Arch Neurol1989;46:48-52.
19.
Gualtieri CT , Hicks RE: Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity. Psychiatr Clin North Am1991;14:113-124.
20.
Filipek PA, Semrud-Clikeman M., Steingard RJ, et al: Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology1997;48:589-601.
21.
Heilman KM, Voeller KK, Nadeau SE: A possible pathophysiologic substrate of attention deficit hyperactivity disorder . J Child Neurol1991;6(Suppl):S76-S81.
22.
Zametkin AJ , Nordahl TE, Gross M., et al: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med1990;323:1361-1366.
23.
Shaywitz BA , Shaywitz SE, Byrne T., et al: Attention deficit disorder: Quantitative analysis of CT. Neurology1983;33:1500-1503.
24.
Hynd GW, Semrud-Clikeman M., Lorys AR, et al: Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Arch Neurol1990;47:919-926.
25.
Castellanos FX, Giedd JN, Eckburg P., et al: Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder . Am J Psychiatry1994;151:1791-1796.
26.
Hynd GW, Hern KL, Novey ES, et al: Attention deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol1993;8:339-347.
27.
Hynd GW, Semrud-Clikeman M., Lorys AR, et al: Corpus callosum morphology in attention deficit-hyperactivity disorder: Morphometric analysis of MRI. J Learn Dis1991;24:141-146.
28.
Semrud-Clikeman M., Filipek PA, Biederman J., et al: Attention deficit hyperactivity disorder: Magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry1994;33:875-881.
29.
Giedd JN, Castellanos FX, Casey BJ, et al: Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry1994;151:665-669.
30.
Castellanos FX, Giedd JN, Marsh WL, et al: Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder . Arch Gen Psychiatry1996;53:607-616.
31.
Baumgardner TL, Singer HS, Denckla MD, et al: Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology1996;47:477-482.
32.
Witelson SF : Hand and sex differences in the isthmus and genu of the human corpus callosum. Brain1989 ;112:799-835.
33.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.
34.
Achenbach TM, Edelbrock CS: Manual for the Child Behavior Checklist and Revised Child Behavior Profile . Burlington, University of Vermont Department of Psychiatry, 1983.
35.
Wirt RD, Lachar D., Klinedinst JK, Seat PD: Multidimensional Description of Child Personality. A Manual for the Personality Inventory for Children. Los Angeles, Western Psychological Services, 1990.
36.
Achenbach TM , Edelbrock CS: Manual for the Teacher's Report Form and Teacher Version of the Child Behavior Profile. Burlington , University of Vermont Department of Psychiatry, 1986.
37.
Hollingshead AB: Two Factor Index of Social Position. New Haven, CT, Yale University Press, 1957.
38.
Baron IS, Fennell EB, Voeller Kks: Neurodevelopmental and genetic syndromes, in Pediatric Neuropsychology in the Medical Setting. New York, Oxford University Press, 1995, pp 64-113.
39.
Schaefer GB , Thompson JN, Bodensteiner JB, et al: Quantitative morphometric analysis of brain growth using magnetic resonance imaging. J Child Neurol1990;5:127-130.
40.
Pujol J., Vendrell P., Junque C., et al: When does human brain development end? Evidence of corpus callosum growth up to adulthood. Ann Neurol1993;34:71-75.
41.
Schaefer GB , Shuman RM, Wilson DA, et al: Partial agenesis of the anterior corpus callosum: Correlation between appearance, imaging, and neuropathology. PediatricNeurol1991 ;7:39-44.
42.
Fletcher JM , Bohan TP, Brandt ME, et al: Cerebral white matter and cognition in hydrocephalic children. Arch Neurol1992 ;49: 818-824.
43.
Dennis MD: Cerebral dominance in three forms of early brain disorder, in Blaw ME, Rapin I, Kinsbourne M (eds): Topics in Child Neurology, New York, Spectrum, 1977, pp 189-212.
44.
Gazzaniga MS : The Bisected Brain. New York, Appleton-Century-Crofts , 1970.
45.
Said SM, Yeh TL, Greenwood RS, et al: MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport1996;7:1941-1944.
46.
MacDonald MR , Schaefer GB: Computerized brain morphometry in neurofibromatosis, type I, in Proceedings of the 9th Annual NNFF Clinical Care Symposium, San Francisco, 1992 .
47.
Danglot G., Regnier V., Fauvet D., et al: Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene. Hum Mol Genet1995;4: 915-920.
48.
Geist RT, Gutmann DH: Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett1996;211:85-88.
49.
The I., Hannagan GE, Cowley GS, et al: Rescue of a Drosophila NF-1 mutant phenotype by protein kinase A. Science1997;276:791-794.
50.
Guo H-F., The I., Hannan H., et al: Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science1997 ;276:795-798.
51.
Gutmann DH: Recent insights into neurofibromatosis type 1. Arch Neurol1998;55:778-780.
